The largest database of trusted experimental protocols

Mapk14 sirna

Manufactured by Thermo Fisher Scientific
Sourced in United States

MAPK14 siRNA is a small interfering RNA (siRNA) that targets the MAPK14 gene, also known as p38 MAPK. It is designed to downregulate the expression of the MAPK14 gene, which is involved in various cellular processes, including stress response, inflammation, and cell differentiation.

Automatically generated - may contain errors

2 protocols using mapk14 sirna

1

Cell Line Maintenance and Treatment Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
MDA-MB-231, T47D, U20S, MG63 and SAOS-2 cell lines were purchased from ATCC. BBL358 cells were generated as described [20 (link)]. All cells were maintained in DMEM high glucose supplemented with 10% FBS, 1% L-Glutamine and 1% penicillin-streptomycin at 37°C and 5% CO2. Treatments were performed with PROTACs at the indicated concentrations or with 1 μM of PH-797804 (Selleckchem #S2726). To induce p38α pathway activation, cells were stimulated with UV (40 J/m2) and collected after 1 h. Cells were treated with 20 μM MG132 (Calbiochem #474790) or 1 μM NAE inhibitor (NEDD8-Activating Enzyme inhibitor, Calbiochem #505477) for 1 h before PROTAC addition. For siRNA transfection, cells were cultured in OPTIMEM, and MAPK14 siRNA (Ambion, #s3586) was used with Lipofectamine RNAiMAX following the manufacturer’s instructions.
+ Open protocol
+ Expand
2

Knockdown of DKK-1 and MAPK Signaling Pathways in PC3 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sub-confluent PC3 cells in six-well dishes were transfected with the following siRNAs using Dharmafect (Thermo Scientific, Waltham, MA, USA): DKK-1 siRNA ID#s: s22723 and s22721 (Ambion, Life Technologies, Carlsbad, CA, USA); MAPK11 siRNA ID#s: MAPK11HSS183382, MAPK11HSS183383 and MAPK11HSS183384 (Invitrogen, Life Technologies, Carlsbad, CA, USA); MAPK12 siRNA ID#s: MAPK12HSS109466, MAPK12HSS109467 and MAPK12HSS109405 (Invitrogen, Life Technologies, Carlsbad CA, USA); MAPK14 siRNA ID#s: s3585, s3586 and s3587 (Ambion, Life Technologies, Carlsbad, CA, USA). Per six-well transfection, 100 nM siRNA were diluted in 50 μl of OPTI-MEM and 2 μl (should be 100 nM amount as varied) of Dharmafect (Invitrogen) in 100 μl of OPTI-MEM. SiRNA and Dharmafect dilutions were incubated at room temperature for 5 min. The diluted siRNA was then combined with the diluted Dharmafect at a ratio of 1 : 2, and incubated at room temperature for 20 min. Cells were washed twice with HBSS and medium replaced with 850 μl of OPTI-MEM supplemented with 10% FCS. In all, 150 μl of the siRNA and Dharmafect mixture was then introduced drop-wise to the cells. After 5 h, the Dharmafect mixture was replaced with the normal culture medium containing both FCS and P/S. The cells were further cultured for 24 h before supernatant was collected and cells lysed for either protein or RNA analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!